Hurler-Scheie Syndrome [clinicaltrials_resource:3285825654ba4c812b7d1b80bbcdf1ad]
A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients [clinicaltrials:NCT00144768]clinicaltrials:NCT00144781clinicaltrials:NCT00146757clinicaltrials:NCT00146770clinicaltrials:NCT00258011A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants [clinicaltrials:NCT00418821]Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I [clinicaltrials:NCT00786968]clinicaltrials:NCT00852358clinicaltrials:NCT00912925clinicaltrials:NCT02298712
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Hurler-Scheie Syndrome [clinicaltrials_resource:3285825654ba4c812b7d1b80bbcdf1ad]
Bio2RDF identifier
3285825654ba4c812b7d1b80bbcdf1ad
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3285825654ba4c812b7d1b80bbcdf1ad
identifier
clinicaltrials_resource:3285825654ba4c812b7d1b80bbcdf1ad
title
Hurler-Scheie Syndrome
@en
type
label
Hurler-Scheie Syndrome [clinicaltrials_resource:3285825654ba4c812b7d1b80bbcdf1ad]
@en